Samuel Sears

Samuel Sears

Director/Board Member at HEDGEPATH PHARMACEUTICALS INC

Net worth: 109 429 $ as of 31/08/2026

82 year
Health Technology
Commercial Services
Retail Trade

Profile

Mr. Samuel J.
Sears
, Jr., is an Independent Director at Inhibitor Therapeutics, Inc. and an Of Counsel at Cetrulo & Capone LLP.
He is on the Board of Directors at Inhibitor Therapeutics, Inc. Mr. Sears was previously employed as an Independent Director by BioDelivery Sciences International, Inc., an Independent Director by Commonwealth Biotechnologies, Inc., a Vice Chairman by American Prescription Providers, Inc., a Chairman & Chief Executive Officer by Star Scientific, Inc., and a Managing Partner by Burns & Levinson LLP.
He also served on the board at Independent Bank Corp.
(Michigan) and The Casual Male, Inc. He received his undergraduate degree from Harvard College and a graduate degree from Boston College Law School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/08/2026 12,29,543 ( 0.71% ) 109 429 $ 31/08/2026

Samuel Sears active positions

CompaniesPositionStart
HEDGEPATH PHARMACEUTICALS INC Director/Board Member 13/12/2022
General Counsel 01/01/2019

Former positions of Samuel Sears

CompaniesPositionEnd
BIODELIVERY SCIENCES INTERNATIONAL, INC. Director/Board Member 21/05/2018
HEDGEPATH PHARMACEUTICALS INC Director/Board Member 30/11/2016
Director/Board Member 19/08/2013
Director/Board Member 01/02/1999
ROCK CREEK PHARMACEUTICALS, INC. Chief Executive Officer 01/05/1998
See the detail of Samuel Sears's experience

Training of Samuel Sears

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

50

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Commercial Services

Health Technology

Health Technology

Retail Trade

Commercial Services

Commercial Services

Retail Trade

Health Technology

Consumer Services

Consumer Services